Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Cytokinetics reported $75.22M in Current Liabilities for its fiscal quarter ending in March of 2023.

Current Liabilities Change
Acadia Pharmaceuticals ACAD:US USD 224.3M 98.67M
Acorda Therapeutics ACOR:US USD 34.74M 3.21M
Amgen AMGN:US USD 14.22B 1.47B
Bayer BAYN:GR EUR 34.39B 693M
Biogen BIIB:US USD 3.01B 257.9M
Brainstorm Cell Therapeutics BCLI:US USD 10.42M 1.62M
Capricor Therapeutics CAPR:US USD 37.13M 13.54M
Cytokinetics CYTK:US USD 75.22M 9.4M
Eisai 4523:JP JPY 298.94B 14.73B
Eli Lilly LLY:US USD 16.01B 1.13B
Exelixis EXEL:US USD 327.6M 3.24M
Geron GERN:US USD 43.91M 32.78M
Halozyme Therapeutics HALO:US USD 91.92M 38.87M
Intra Cellular Therapies ITCI:US USD 79.59M 3.65M
Ionis Pharmaceuticals IONS:US USD 259.22M 52.34M
Ligand Pharmaceuticals LGND:US USD 98.93M 119K
Novartis NOVN:VX USD 30.55B 1.89B
Regeneron Pharmaceuticals REGN:US USD 3.1B 41.2M
Roche Holding ROG:VX CHF 27.24B 170M